Pharma & Biotech

Shares of Viking Therapeutics experienced a significant surge this week, driven by a series of strategic updates and a notable...

Presenting at the J.P. Morgan Healthcare Conference, Adma Biologics significantly upgraded its financial outlook, introducing detailed projections that extend to...

The publication of peer-reviewed final data from two pivotal Phase 3 trials has dealt a definitive blow to Cassava Sciences'...

The recent upward momentum for Bionxt Solutions has hit a significant obstacle. Shares in the bioscience company reversed sharply on...

BioNTech is executing a deliberate strategy to evolve beyond its identity as a COVID-19 vaccine specialist and refocus on its...

Shares of Viking Therapeutics, a clinical-stage biotechnology firm, experienced a significant rally, closing at $34.34 with a gain of approximately...

The final chapter for Tübingen-based mRNA pioneer CureVac on public markets is now written. A turbulent period in German stock...

A notable shift is occurring in the shareholder base of IQVIA Holdings Inc., the global provider of advanced analytics, technology...

The final chapter has closed for CureVac as a publicly traded entity. The German biotech firm, once a beacon of...

In a strategic pivot aimed at capturing a broader patient base, Novo Nordisk is aggressively promoting a new oral version...